The generic name for Pristiq is desvenlafaxine [1]. Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder [1].
When is desvenlafaxine expected to be available generically?
The patent for desvenlafaxine has expired, allowing for the potential introduction of generic versions [2]. Information from DrugPatentWatch.com indicates that the patent protection has concluded, paving the way for generic competition [2].
What is desvenlafaxine and how does it work?
Desvenlafaxine is the active metabolite of the antidepressant venlafaxine [1]. It works by increasing the levels of serotonin and norepinephrine in the brain, which are neurotransmitters that play a role in mood regulation [1].
Who manufactures generic desvenlafaxine?
Several pharmaceutical companies are expected to manufacture generic desvenlafaxine. The availability of generic versions typically increases competition and can lead to lower prices [3].
What is the difference between desvenlafaxine and venlafaxine?
Desvenlafaxine is the primary active metabolite of venlafaxine, meaning that after venlafaxine is taken, the body converts it into desvenlafaxine [1]. Desvenlafaxine is also available as a direct medication, bypassing the conversion step in the body [1].
What are the potential side effects of desvenlafaxine?
Common side effects of desvenlafaxine can include nausea, dizziness, insomnia, and sweating [1]. As with any medication, patients should discuss potential side effects with their healthcare provider [1].
What clinical data supports desvenlafaxine's efficacy?
Clinical trials have demonstrated the efficacy of desvenlafaxine in treating major depressive disorder [1]. These studies typically involve comparing the drug's effects to a placebo or other established treatments [1].
Sources:
[1] https://www.nhs.uk/medicine-guides/pages/medicineoverview.aspx?medicine=DESVENLAFAXINE
[2] https://www.drugpatentwatch.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063091/